Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...